Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7153 - 7160 of 12011 results
Briefs Filed in CalPERS v. ANZ Securities
March 24, 2017| Blog| Viewpoint
Registration Still Open for Mintz’s Third Annual Employment Law Summit (April 6, 2017)
March 23, 2017| Blog| Viewpoint
Future of the Affordable Care Act and the American Health Care Act
March 23, 2017| Blog| Viewpoint
Upcoming Event: E2’s Why Clean Energy Will Win: Technologies That Can Change The World (March 29)
March 22, 2017| Blog| Viewpoint
Mintz 3rd Annual Employment Law Summit – Advancing the Ball on Pay Equity
March 22, 2017| Blog| Viewpoint
EU General Data Protection Regulation Webinar Series
March 22, 2017| Blog| Viewpoint
Global Dossier Expanded To More Patent Applications Around the World
March 22, 2017| Blog| Viewpoint
US and UK Limit the Size of Electronic Devices in Carry-On Luggage in Airplanes Originating from Eight Muslim-Majority Countries
March 22, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|